| [1] | Freireich EJ (2000) Supportive care for patients with blood disorders. Br J Haematol 111: 68–77.
|
| [2] | Jendiroba DB, Freireich EJ (2000) Granulocyte transfusions: from neutrophil replacement to immunereconstitution. Blood Rev 14: 219–227.
|
| [3] | Rebulla P (2005) A mini-review on platelet refractoriness. Haematologica 90: 247–253.
|
| [4] | Sachs UJ (2007) The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion. Transfus Apher Sci 37: 273–282.
|
| [5] | Winters JL (2006) Complications of donor apheresis. J Clin Apher 21: 132–141.
|
| [6] | Weissman IL (2000) Stem cells: units of development, units of regeneration, and units in evolution. Cell 100: 157–168.
|
| [7] | Orkin SH, Zon LI (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132: 631–644.
|
| [8] | Hochedlinger K, Jaenisch R (2006) Nuclear reprogramming and pluripotency. Nature 441: 1061–1067.
|
| [9] | Korbling M, Katz RL, Khanna A, Ruifrok AC, Rondon G, et al. (2002) Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 346: 738–746.
|
| [10] | Slack JM (2007) Metaplasia and transdifferentiation: from pure biology to the clinic. Nat Rev Mol Cell Biol 8: 369–378.
|
| [11] | Eglitis MA, Mezey E (1997) Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A 94: 4080–4085.
|
| [12] | Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, et al. (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390–394.
|
| [13] | Brazelton TR, Rossi FM, Keshet GI, Blau HM (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290: 1775–1779.
|
| [14] | Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, et al. (2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6: 1229–1234.
|
| [15] | Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369–377.
|
| [16] | Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL (1999) Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283: 534–537.
|
| [17] | Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, et al. (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3: 778–784.
|
| [18] | Okamoto R, Yajima T, Yamazaki M, Kanai T, Mukai M, et al. (2002) Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 8: 1011–1017.
|
| [19] | Korbling M, Estrov Z (2003) Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med 349: 570–582.
|
| [20] | Wagers AJ, Weissman IL (2004) Plasticity of adult stem cells. Cell 116: 639–648.
|
| [21] | Gurdon JB (2006) From nuclear transfer to nuclear reprogramming: the reversal of cell differentiation. Annu Rev Cell Dev Biol 22: 1–22.
|
| [22] | Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676.
|
| [23] | Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861–872.
|
| [24] | Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917–1920.
|
| [25] | Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920–1923.
|
| [26] | Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318–324.
|
| [27] | Park IH, Zhao R, West JA, Yabuuchi A, Huo H, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141–146.
|
| [28] | Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218–1221.
|
| [29] | Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, et al. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457: 277–280.
|
| [30] | Choi J, Costa ML, Mermelstein CS, Chagas C, Holtzer S, et al. (1990) MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci U S A 87: 7988–7992.
|
| [31] | Shen CN, Slack JM, Tosh D (2000) Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2: 879–887.
|
| [32] | Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell 117: 663–676.
|
| [33] | Cobaleda C, Jochum W, Busslinger M (2007) Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449: 473–477.
|
| [34] | Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, et al. (2005) Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 11: 271–276.
|
| [35] | Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455: 627–632.
|
| [36] | Jones PA (1985) Altering gene expression with 5-azacytidine. Cell 40: 485–486.
|
| [37] | Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6–21.
|
| [38] | Feinberg AP, Vogelstein B (1983) Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 111: 47–54.
|
| [39] | Issa JP (2007) DNA methylation as a therapeutic target in cancer. Clin Cancer Res 13: 1634–1637.
|
| [40] | Constantinides PG, Jones PA, Gevers W (1977) Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature 267: 364–366.
|
| [41] | Constantinides PG, Taylor SM, Jones PA (1978) Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. Dev Biol 66: 57–71.
|
| [42] | Boyd AW, Schrader JW (1982) Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature 297: 691–693.
|
| [43] | Kaminskas E, Farrell A, Abraham S, Baird A, Hsieh LS, et al. (2005) Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes. Clin Cancer Res 11: 3604–3608.
|
| [44] | Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726–736.
|
| [45] | Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R (2003) Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101: 2999–3001.
|
| [46] | Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, et al. (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5: 309–313.
|
| [47] | Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, et al. (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99: 8932–8937.
|
| [48] | Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, et al. (2002) Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30: 215–222.
|
| [49] | Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16: 557–564.
|
| [50] | Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, et al. (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18: 307–316.
|
| [51] | Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, et al. (2005) Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11: 389–398.
|
| [52] | Ball LM, Bernardo ME, Locatelli F, Egeler RM (2008) Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT. Bone Marrow Transplant 42: Suppl 2S60–66.
|
| [53] | Wood B (2006) 9-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med 130: 680–690.
|
| [54] | Kundra V, Mannting F, Jones AG, Kassis AI (2002) Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer. J Nucl Med 43: 406–412.
|
| [55] | Zhou Q, Melton DA (2008) Extreme makeover: converting one cell into another. Cell Stem Cell 3: 382–388.
|
| [56] | Argiropoulos B, Humphries RK (2007) Hox genes in hematopoiesis and leukemogenesis. Oncogene 26: 6766–6776.
|
| [57] | Ivins S, Pemberton K, Guidez F, Howell L, Krumlauf R, et al. (2003) Regulation of Hoxb2 by APL-associated PLZF protein. Oncogene 22: 3685–3697.
|
| [58] | Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, et al. (1994) Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A 91: 12223–12227.
|
| [59] | Pineault N, Helgason CD, Lawrence HJ, Humphries RK (2002) Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol 30: 49–57.
|
| [60] | Sachan M, Raman R (2006) Developmental methylation of the regulatory region of HoxB5 gene in mouse correlates with its tissue-specific expression. Gene 380: 151–158.
|
| [61] | Hershko AY, Kafri T, Fainsod A, Razin A (2003) Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse development. Gene 302: 65–72.
|
| [62] | Sorm F, Piskala A, Cihak A, Vesely J (1964) 5-Azacytidine, a new, highly effective cancerostatic. Experientia 20: 202–203.
|
| [63] | Taylor SM, Jones PA (1979) Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17: 771–779.
|
| [64] | Chiu CP, Blau HM (1985) 5-Azacytidine permits gene activation in a previously noninducible cell type. Cell 40: 417–424.
|
| [65] | Konieczny SF, Emerson CP Jr (1984) 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination. Cell 38: 791–800.
|
| [66] | Choi SC, Yoon J, Shim WJ, Ro YM, Lim DS (2004) 5-azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med 36: 515–523.
|
| [67] | Enjoji M, Nakashima M, Honda M, Sakai H, Nawata H (1997) Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine. Hepatology 26: 288–294.
|
| [68] | Darmon M, Nicolas JF, Lamblin D (1984) 5-Azacytidine is able to induce the conversion of teratocarcinoma-derived mesenchymal cells into epithelia cells. Embo J 3: 961–967.
|
| [69] | Lassar AB, Paterson BM, Weintraub H (1986) Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 47: 649–656.
|
| [70] | Broxmeyer HE, Maze R, Miyazawa K, Carow C, Hendrie PC, et al. (1991) The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells 3: 480–487.
|
| [71] | McNiece IK, Langley KE, Zsebo KM (1991) Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19: 226–231.
|
| [72] | Lennartsson J, Shivakrupa R, Linnekin D (2004) Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit. J Biol Chem 279: 44544–44553.
|
| [73] | Broxmeyer HE, Lu L, Hangoc G, Cooper S, Hendrie PC, et al. (1991) CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand). J Exp Med 174: 447–458.
|
| [74] | McNiece IK, Langley KE, Zsebo KM (1991) The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7. J Immunol 146: 3785–3790.
|
| [75] | Hirohata S, Yanagida T, Tomita T, Yoshikawa H, Ochi T (2002) Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD- B cells through direct cellular interaction. J Leukoc Biol 71: 987–995.
|
| [76] | Sonderegger I, Iezzi G, Maier R, Schmitz N, Kurrer M, et al. (2008) GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J Exp Med 205: 2281–2294.
|
| [77] | Ma F, Yang F, Kaneko A, Manabe A, Tanaka R, et al. (2000) Cytokine requirement for the development of T-lymphoid lineage potential in clonal lymphohaematopoietic progenitors in vitro. Br J Haematol 111: 1170–1179.
|
| [78] | Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184: 1101–1109.
|
| [79] | Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, et al. (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52: 145–176.
|
| [80] | Burger JA, Burger M, Kipps TJ (1999) Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 94: 3658–3667.
|
| [81] | Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, et al. (2002) Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46: 3349–3360.
|
| [82] | Krumlauf R (1994) Hox genes in vertebrate development. Cell 78: 191–201.
|
| [83] | Connell D, Datir A, Alyas F, Curtis M (2009) Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med.
|
| [84] | Yamada N, Uchinuma E, Matsumoto Y, Kuroyanagi Y (2008) Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute. J Artif Organs 11: 221–224.
|
| [85] | Yu BD, Mukhopadhyay A, Wong C (2008) Skin and hair: models for exploring organ regeneration. Hum Mol Genet 17: R54–59.
|
| [86] | Schmidt AH, Stahr A, Baier D, Schumacher S, Ehninger G, et al. (2007) Selective recruitment of stem cell donors with rare human leukocyte antigen phenotypes. Bone Marrow Transplant 40: 823–830.
|
| [87] | Gluckman E, Wagner JE (2008) Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant 41: 127–132.
|
| [88] | Tse W, Bunting KD, Laughlin MJ (2008) New insights into cord blood stem cell transplantation. Curr Opin Hematol 15: 279–284.
|
| [89] | Sauter C, Barker JN (2008) Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies. Curr Opin Hematol 15: 568–575.
|
| [90] | Hai-Jiang W, Xin-Na D, Hui-Jun D (2008) Expansion of hematopoietic stem/progenitor cells. Am J Hematol 83: 922–926.
|
| [91] | Haylock DN, Nilsson SK (2007) Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther 2: 324–335.
|
| [92] | Alvarnas JC, Forman SJ (2004) Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled. Oncology (Williston Park) 18: 867–876; discussion 876-868, 881, 884.
|
| [93] | Thirukkumaran CM, Russell JA, Stewart DA, Morris DG (2007) Viral purging of haematological autografts: should we sneeze on the graft? Bone Marrow Transplant 40: 1–12.
|
| [94] | Habib M, Fares F, Bourgeois CA, Bella C, Bernardino J, et al. (1999) DNA global hypomethylation in EBV-transformed interphase nuclei. Exp Cell Res 249: 46–53.
|
| [95] | Milutinovic S, Zhuang Q, Niveleau A, Szyf M (2003) Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J Biol Chem 278: 14985–14995.
|
| [96] | Fauser AA, Messner HA (1978) Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. Blood 52: 1243–1248.
|
| [97] | Yang D, Han L, Kundra V (2005) Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology 235: 950–958.
|
| [98] | Pounds S, Morris SW (2003) Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values. Bioinformatics 19: 1236–1242.
|
